blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3598975

EP3598975 - NOVEL COMBINATIONS OF A H3 ANTAGONIST AND A NORADRENALINE REUPTAKE INHIBITOR, AND THE THERAPEUTICAL USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.08.2021
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  18.09.2020
FormerGrant of patent is intended
Status updated on  02.03.2020
FormerExamination is in progress
Status updated on  03.07.2019
Most recent event   Tooltip03.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 05.06.2024  [2024/23]
Applicant(s)For all designated states
Bioprojet
30 rue des Francs Bourgeois
75003 Paris / FR
[2020/05]
Inventor(s)01 / LIGNEAU, Xavier
4 Square du Vivier Louis
35760 Saint-Grégoire / FR
02 / LANDAIS, Laurent
5 Le Haut Chemin
35340 Ercé-Près-Liffré / FR
03 / PERRIN, David
11 Rue des Pêchers
35850 Gévezé / FR
04 / LECOMTE, Jeanne Marie
30 rue des Francs-Bourgeois
75003 Paris / FR
05 / SCHWARTZ, Jean Charles
9 Villa Seurat
75014 Paris / FR
 [2020/43]
Former [2020/05]01 / LIGNEAU, Xavier
4 Square du Vivier Louis
35760 Saint-Grégoire / FR
02 / LANDAIS, Laurent
5 Le haut Chemin
35340 Ercé-Près-Liffré / FR
03 / PERRIN, David
11 Rue des Pêchers
35340 Gévezé / FR
04 / LECOMTE, Jeanne Marie
30 rue des Francs-Bourgeois
75003 Paris / FR
05 / SCHWARTZ, Jean Charles
9 Villa Seurat
75014 Paris / FR
Representative(s)Lavoix
2, place d'Estienne d'Orves
75441 Paris Cedex 09 / FR
[2020/05]
Application number, filing date18306017.727.07.2018
[2020/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3598975
Date:29.01.2020
Language:EN
[2020/05]
Type: B1 Patent specification 
No.:EP3598975
Date:21.10.2020
Language:EN
[2020/43]
Search report(s)(Supplementary) European search report - dispatched on:EP12.02.2019
ClassificationIPC:A61K31/445, A61K31/4545, A61K31/135, A61K31/381, A61K31/535, A61K31/55, A61P25/00, A61K45/06
[2020/05]
CPC:
A61K31/445 (EP); A61K31/4453 (CN,IL,KR,US); A61K31/4545 (EP,CN,IL,KR,US);
A61K31/135 (EP); A61K31/137 (CN,IL); A61K31/381 (EP,CN,KR,US);
A61K31/535 (EP); A61K31/5375 (CN,IL); A61K31/55 (EP,KR);
A61K45/06 (EP); A61P11/00 (CN); A61P25/00 (EP,CN,IL,KR);
A61P25/14 (CN); A61P25/16 (CN); A61P25/24 (CN,IL,KR);
A61P25/26 (CN,US); A61P25/28 (CN); A61P25/30 (IL,KR);
A61P25/32 (CN,IL); C07D295/092 (KR); C07D401/12 (KR);
A61K2300/00 (KR) (-)
C-Set:
A61K31/135, A61K2300/00 (EP);
A61K31/137, A61K2300/00 (CN);
A61K31/381, A61K2300/00 (EP,CN);
A61K31/4453, A61K2300/00 (CN);
A61K31/445, A61K2300/00 (EP);
A61K31/4545, A61K2300/00 (EP,CN);
A61K31/535, A61K2300/00 (EP);
A61K31/5375, A61K2300/00 (CN);
A61K31/55, A61K2300/00 (EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/05]
TitleGerman:NEUARTIGE KOMBINATIONEN EINES H3-ANTAGONISTEN UND NORADRENALIN-WIEDERAUFNAHMEHEMMERS UND DEREN THERAPEUTISCHEN VERWENDUNGEN[2020/05]
English:NOVEL COMBINATIONS OF A H3 ANTAGONIST AND A NORADRENALINE REUPTAKE INHIBITOR, AND THE THERAPEUTICAL USES THEREOF[2020/05]
French:NOUVELLES COMBINAISONS D'UN ANTAGONISTE H3 ET UN INHIBITEUR DE LA RECAPTURE DE LA NORADRÉNALINE ET LEURS UTILISATIONS THÉRAPEUTIQUES[2020/05]
Examination procedure13.03.2019Examination requested  [2020/05]
13.03.2019Date on which the examining division has become responsible
14.03.2019Amendment by applicant (claims and/or description)
08.07.2019Despatch of a communication from the examining division (Time limit: M06)
29.08.2019Reply to a communication from the examining division
28.10.2019Despatch of a communication from the examining division (Time limit: M04)
15.11.2019Reply to a communication from the examining division
03.03.2020Communication of intention to grant the patent
20.04.2020Fee for grant paid
20.04.2020Fee for publishing/printing paid
20.04.2020Receipt of the translation of the claim(s)
Opposition(s)22.07.2021No opposition filed within time limit [2021/39]
Fees paidRenewal fee
16.06.2020Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL21.10.2020
CY21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
MK21.10.2020
RS21.10.2020
SI21.10.2020
SM21.10.2020
BG21.01.2021
[2024/23]
Former [2023/30]AL21.10.2020
CY21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
RS21.10.2020
SI21.10.2020
SM21.10.2020
BG21.01.2021
Former [2022/18]AL21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
RS21.10.2020
SI21.10.2020
SM21.10.2020
BG21.01.2021
Former [2021/50]AL21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
RS21.10.2020
SI21.10.2020
SM21.10.2020
BG21.01.2021
Former [2021/45]AL21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
RS21.10.2020
SM21.10.2020
BG21.01.2021
Former [2021/33]HR21.10.2020
LT21.10.2020
LV21.10.2020
RS21.10.2020
SM21.10.2020
BG21.01.2021
Former [2021/32]HR21.10.2020
LV21.10.2020
RS21.10.2020
SM21.10.2020
BG21.01.2021
Former [2021/28]HR21.10.2020
LV21.10.2020
RS21.10.2020
BG21.01.2021
Former [2021/24]LV21.10.2020
RS21.10.2020
BG21.01.2021
Former [2021/23]LV21.10.2020
RS21.10.2020
Former [2021/22]RS21.10.2020
Documents cited:Search[AD]WO2006117609  (BIOPROJET SOC CIV [FR], et al);
by applicantWO2006117609
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.